Antigen Record Ag001677

AgACCAg001677
Date04-08-2008
Last updated14-12-2016
Antigen NameABCC3
Common NameMultidrug resistance-associated protein 3 (MRP3)
Full NameATP-binding cassette, sub-family C (CFTR/MRP), member 3
SynonymATP-binding cassette sub-family C member 3; ATP-binding cassette, sub-family C (CFTR/MRP), member 3; ATP-binding cassette, sub-family C, member 3; Canalicular multispecific organic anion transporter 2; Highly similar to MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 [Homo sapiens]; Multi-specific organic anion transporter-D; Multidrug resistance-associated protein 3; canicular multispecific organic anion transporter; multidrug resistance associated protein; ABC31; CMOAT2; EST90757; MLP2; MOAT-D; MRP3; cMOAT2

another display format
  • ATP-binding cassette sub-family C member 3
  • ATP-binding cassette, sub-family C (CFTR/MRP), member 3
  • ATP-binding cassette, sub-family C, member 3
  • Canalicular multispecific organic anion transporter 2
  • Highly similar to MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 [Homo sapiens]
  • Multi-specific organic anion transporter-D
  • Multidrug resistance-associated protein 3
  • canicular multispecific organic anion transporter
  • multidrug resistance associated protein
  • ABC31
  • CMOAT2
  • EST90757
  • MLP2
  • MOAT-D
  • MRP3
  • cMOAT2
UniProt IDQ59H05
NCBI Gene ID8714
GeneCard IDGC17P050634
AnnotationThis is a fragment sequence.
IsoformsAg000410,  Ag000411,  Ag000412,  Ag000413,  Ag002054

Alignment of all Isoforms
Mutation entriesAg004054,  Ag004055,  Ag004056,  Ag004057,  Ag004058,  Ag004059,  Ag004060,  Ag004061

View mutation map
RNA/protein expression profileRNA and protein Expression profile
T cell epitopeEpitope sequencePositionHLA alleleReference
AYVPQQAWI698-706 A*2402  11522641
LYAWEPSFL509-517 A*2402  11522641
NYSVRYRPGL1299-1308 A*2402  11522641
VYSDADIFL771-779 A*2402  11522641
Predicted HLA binders
Allele:  predictions
Peptide length:   
Antigen sequenceQPRLGPMDALCGSGELGSKFWDSNLSVHTENPDLTPCFQNSLLAWVPCIYLWVALPCYLLYLRHHCRGYI
ILSHLSKLKMVLGVLLWCVSWADLFYSFHGLVHGRAPAPVFFVTPLVVGVTMLLATLLIQYERLQGVQSS
GVLIIFWFLCVVCAIVPFRSKILLAKAEGEISDPFRFTTFYIHFALVLSALILACFREKPPFFSAKNVDP
NPYPETSAGFLSRLFFWWFTKMAIYGYRHPLEEKDLWSLKEEDRSQMVVQQLLEAWRKQEKQTARHKASA
APGKNASGEDEVLLGARPRPRKPSFLKALLATFGSSFLISACFKLIQDLLSFINPQLLSILIRFISNPMA
PSWWGFLVAGLMFLCSMMQSLILQHYYHYIFVTGVKFRTGIMGVIYRKALVITNSVKRASTVGEIVNLMS
VDAQRFMDLAPFLNLLWSAPLQIILAIYFLWQNLGPSVLAGVAFMVLLIPLNGAVAVKMRAFQVKQMKLK
DSRIKLMSEILNGIKVLKLYAWEPSFLKQVEGIRQGELQLLRTAAYLHTTTTFTWMCSPFLVTLITLWVY
VYVDPNNVLDAEKAFVSVSLFNILRLPLNMLPQLISNLTQASVSLKRIQQFLSQEELDPQSVERKTISPG
YAITIHSGTFTWAQDLPPTLHSLDIQVPKGALVAVVGPVGCGKSSLVSALLGEMEKLEGKVHMKGSVAYV
PQQAWIQNCTLQENVLFGKALNPKRYQQTLEACALLADLEMLPGGDQTEIGEKGINLSGGQRQRVSLARA
VYSDADIFLLDDPLSAVDSHVAKHIFDHVIGPEGVLAGKTRVLVTHGISFLPQTDFIIVLADGQVSEMGP
YPALLQRNGSFANFLCNYAPDEDQGHLEDSWTALEGAEDKEALLIEDTLSNHTDLTDNDPVTYVVQKQFM
RQLSALSSDGEGQGRPVPRRHLGPSEKVQVTEAKADGALTQEEKAAIGTVELSVFWDYAKAVGLCTTLAI
CLLYVGQSAAAIGANVWLSAWTNDAMADSRQNNTSLRLGVYAALGILQGFLVMLAAMAMAAGGIQAARVL
HQALPHNKIRSPQSFFDTTPSGRILNCFSKDIYVVDEVLAPVILMLLNSFFNAISTLVVIMASTPLFTVV
ILPLAVLYTLVQRFYAATSRQLKRLESVSRSPIYSHFSETVTGASVIRAYNRSRDFEIISDTKVDANQRS
CYPYIISNRWLSIGVEFVGNCVVLFAALFAVIGRSSLNPGLVGLSVSYSLQVTFALNWMIRMMSDLESNI
VAVERVKEYSKTETEAPWVVEGSRPPEGWPPRGEVEFRNYSVRYRPGLDLVLRDLSLHVHGGEKVGIVGR
TGAGKSSMTLCLFRILEAAKGEIRIDGLNVADIGLHDLRSQLTIIPQDPILFSGTLRMNLDPFGSYSEED
IWWALELSHLHTFVSSQPAGLDFQCSEGGENLSVGQRQLVCLARALLRKSRILVLDEATAAIDLETDNLI
QATIRTQFDTCTVLTIAHRLNTIMDYTRVLVLDKGVVAEFDSPANLIAARGIFYGMARDAGLA